SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-007694
Filing Date
2022-01-12
Accepted
2022-01-12 16:16:00
Documents
12
Period of Report
2022-01-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d247889d8k.htm   iXBRL 8-K 24749
  Complete submission text file 0001193125-22-007694.txt   150325

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imgo-20220112.xsd EX-101.SCH 2879
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgo-20220112_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgo-20220112_pre.xml EX-101.PRE 11851
6 EXTRACTED XBRL INSTANCE DOCUMENT d247889d8k_htm.xml XML 3490
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650 325 5156
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40604 | Film No.: 22526744
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences